Refractory Hyperlipidemia clinical trials

Explore recruiting refractory hyperlipidemia clinical trials.

Recruiting refractory hyperlipidemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Hyperlipidemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Refractory Hyperlipidemia trials by city

Refractory Hyperlipidemia in Toronto Refractory Hyperlipidemia in Vancouver Refractory Hyperlipidemia in Montreal Refractory Hyperlipidemia in Calgary Refractory Hyperlipidemia in Edmonton Refractory Hyperlipidemia in Ottawa Refractory Hyperlipidemia in Winnipeg Refractory Hyperlipidemia in Quebec City Refractory Hyperlipidemia in Hamilton Refractory Hyperlipidemia in Kitchener Refractory Hyperlipidemia in London Refractory Hyperlipidemia in Halifax Refractory Hyperlipidemia in New York Refractory Hyperlipidemia in Los Angeles Refractory Hyperlipidemia in Chicago Refractory Hyperlipidemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease